Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antitumor Activity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07603791
What this trial is testing

Phase II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of ALK202 for Injection in Combination With Drugs in NSCLC Participants.

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)
Shanghai Allink Biotherapeutics Co., Ltd. 252
Early research (Phase 1)Looking for participantsNCT06372717
What this trial is testing

Investigate APL-4098 Alone and in Combination in Adults With AML or MDS

Who this might be right for
Acute Myeloid Leukemia RefractoryMyelodysplastic Syndrome Acute Myeloid LeukemiaMyelodysplastic Syndrome With Excess Blasts+2 more
Apollo Therapeutics Ltd 100
Early research (Phase 1)Looking for participantsNCT07362888
What this trial is testing

First-in-Human Study of ADCE-B05 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumors (Phase 1)
Adcendo ApS 180
Early research (Phase 1)Looking for participantsNCT06927297
What this trial is testing

Phase I Study of the Safety, Tolerability, and Efficacy of an Engineered Mitochondrial Vaccine in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor MalignanciesAdvanced Solid Malignancies
West China Hospital 12
Early research (Phase 1)Not Yet RecruitingNCT06691360
What this trial is testing

AK137 (Bispecific Antibody Targeting CD73 and LAG-3) in Patients With Advanced Malignant Tumors

Who this might be right for
Advanced Malignant Tumors
Akeso 87
Early research (Phase 1)Active Not RecruitingNCT04522323
What this trial is testing

Evaluate MEDI5752 and Axitinib in Subjects With Advanced Renal Cell Carcinoma

Who this might be right for
Advanced Renal Cell Carcinoma
MedImmune LLC 67
Early research (Phase 1)Ended earlyNCT06285097
What this trial is testing

PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors

Who this might be right for
NeoplasmsNon-small-cell Lung CancerMelanoma+5 more
Pfizer 9
Early research (Phase 1)Ended earlyNCT03203525
What this trial is testing

Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer

Who this might be right for
Advanced Malignant NeoplasmColorectal Carcinoma Metastatic in the LiverMetastatic Malignant Neoplasm in the Liver+1 more
M.D. Anderson Cancer Center 38
Early research (Phase 1)UnknownNCT03669601
What this trial is testing

AZD6738 & Gemcitabine as Combination Therapy

Who this might be right for
Cancer
CCTU- Cancer Theme 55
Early research (Phase 1)WithdrawnNCT05644626
What this trial is testing

Safety, Pharmacokinetics and Antitumor Activity of BGB-B167 Alone and in Combination With Tislelizumab in Participants With Solid Tumors in Chinese Participants

Who this might be right for
Solid Tumors
BeiGene
Early research (Phase 1)Active Not RecruitingNCT04606433
What this trial is testing

Phase I Clinical Study of GNC-038 in Patients With Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia

Who this might be right for
Non Hodgkin LymphomaAcute Lymphoblastic Leukemia
Sichuan Baili Pharmaceutical Co., Ltd. 47
Early research (Phase 1)UnknownNCT04325711
What this trial is testing

CSPCHA131 in Patients With Advanced Solid Tumor

Who this might be right for
Advanced Solid Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 100
Testing effectiveness (Phase 2)Looking for participantsNCT07744763
What this trial is testing

A Phase I/IIa Study of SYS6041 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
CSPC Megalith Biopharmaceutical Co.,Ltd. 260
Early research (Phase 1)Ended earlyNCT06568614
What this trial is testing

An Investigational Study of BG-89894 Tablets in Participants With Advanced Solid Tumors

Who this might be right for
Advanced or Metastatic MTAP-deleted Solid Tumors
BeOne Medicines 29
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07581314
What this trial is testing

Oral Zn-Telomir Monotherapy in Patients With Advanced or Metastatic Triple-Negative Breast Cancer (TNBC)

Who this might be right for
Triple-Negative Breast Cancer (TNBC)Advanced Triple-Negative Breast CancerMetastatic Triple-negative Breast Cancer
Telomir Pharmaceuticals, Inc. 76
Early research (Phase 1)Looking for participantsNCT06625593
What this trial is testing

A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
BeOne Medicines 168
Testing effectiveness (Phase 2)UnknownNCT04669587
What this trial is testing

ER+/HER2- Locally Advanced or Metastatic Breast Cancer (ENZENO Study)

Who this might be right for
Estrogen Receptor-PositiveHER2-NegativeLocally Advanced Breast Cancer+1 more
EnhancedBio USA Inc. 106
Early research (Phase 1)Not Yet RecruitingNCT06755242
What this trial is testing

GNC-077 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors

Who this might be right for
Gastrointestinal TumorsSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 20
Testing effectiveness (Phase 2)Looking for participantsNCT06922591
What this trial is testing

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

Who this might be right for
PDACPDAC - Pancreatic Ductal AdenocarcinomaNSCLC+5 more
Tango Therapeutics, Inc. 183
Early research (Phase 1)Ended earlyNCT06585488
What this trial is testing

A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification

Who this might be right for
Metastatic Solid TumorsAdvanced Non-squamous Non-small-cell Lung CancerAdvanced Colorectal Cancer+4 more
BeOne Medicines 47
Next Page